David Lichter

1.7k total citations
31 papers, 1.2k citations indexed

About

David Lichter is a scholar working on Neurology, Clinical Psychology and Psychiatry and Mental health. According to data from OpenAlex, David Lichter has authored 31 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Neurology, 11 papers in Clinical Psychology and 5 papers in Psychiatry and Mental health. Recurrent topics in David Lichter's work include Parkinson's Disease Mechanisms and Treatments (12 papers), Obsessive-Compulsive Spectrum Disorders (11 papers) and Neurological disorders and treatments (8 papers). David Lichter is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (12 papers), Obsessive-Compulsive Spectrum Disorders (11 papers) and Neurological disorders and treatments (8 papers). David Lichter collaborates with scholars based in United States, Italy and Australia. David Lichter's co-authors include Roger Kurlan, Jeffrey L. Cummings, Linda A. Hershey, David Hewitt, Ira Shoulson, Lisa A. Jackson, William R. Woodward, John G. Nutt, Thomas Guttuso and Carson J. Miller and has published in prestigious journals such as Neurology, Annals of Neurology and Neurobiology of Aging.

In The Last Decade

David Lichter

30 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David Lichter United States	21	551	365	341	286	166	31	1.2k
Sarah Duff‐Canning Canada	18	1.0k 1.8×	285 0.8×	386 1.1×	379 1.3×	201 1.2×	24	1.5k
Antonella Macerollo United Kingdom	23	839 1.5×	224 0.6×	234 0.7×	296 1.0×	323 1.9×	75	1.4k
Chiara Siri Italy	20	1.2k 2.2×	306 0.8×	283 0.8×	172 0.6×	294 1.8×	37	1.4k
Stacy Horn United States	13	1.1k 2.0×	259 0.7×	298 0.9×	245 0.9×	226 1.4×	19	1.5k
Teri Thomsen United States	10	928 1.7×	389 1.1×	263 0.8×	284 1.0×	182 1.1×	16	1.3k
Mircea Polosan France	20	592 1.1×	457 1.3×	505 1.5×	342 1.2×	214 1.3×	95	1.4k
Alicja Lerner United States	13	252 0.5×	258 0.7×	323 0.9×	125 0.4×	276 1.7×	17	893
Trevor A. Hurwitz Canada	24	728 1.3×	246 0.7×	510 1.5×	455 1.6×	285 1.7×	49	1.9k
Sule Tinaz United States	21	529 1.0×	167 0.5×	385 1.1×	177 0.6×	247 1.5×	47	1.2k
Silvia Facchini Italy	17	425 0.8×	96 0.3×	252 0.7×	192 0.7×	95 0.6×	35	1.0k

Countries citing papers authored by David Lichter

Since Specialization

Citations

This map shows the geographic impact of David Lichter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Lichter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Lichter more than expected).

Fields of papers citing papers by David Lichter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Lichter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Lichter. The network helps show where David Lichter may publish in the future.

Co-authorship network of co-authors of David Lichter

This figure shows the co-authorship network connecting the top 25 collaborators of David Lichter. A scholar is included among the top collaborators of David Lichter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Lichter. David Lichter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lichter, David & Linda A. Hershey. (2023). Proposal to Add FDG-PET as an Outcome Measure for Clinical Trials in Patients With Prodromal Lewy Body Dementia. Neurology. 101(15). 666–667. 1 indexed citations

Lichter, David, Ralph Benedict, & Linda A. Hershey. (2021). Freezing of Gait in Parkinson’s Disease: Risk Factors, Their Interactions, and Associated Nonmotor Symptoms. Parkinson s Disease. 2021. 1–12. 22 indexed citations

Jakimovski, Dejan, Niels Bergsland, Michael G. Dwyer, et al.. (2020). Long-standing multiple sclerosis neurodegeneration: volumetric magnetic resonance imaging comparison to Parkinson’s disease, mild cognitive impairment, Alzheimer’s disease, and elderly healthy controls. Neurobiology of Aging. 90. 84–92. 17 indexed citations

Guttuso, Thomas, et al.. (2019). Targeting kinases in Parkinson's disease: A mechanism shared by LRRK2, neurotrophins, exenatide, urate, nilotinib and lithium. Journal of the Neurological Sciences. 402. 121–130. 24 indexed citations

Guttuso, Thomas, Niels Bergsland, Jesper Hagemeier, et al.. (2018). Substantia Nigra Free Water Increases Longitudinally in Parkinson Disease. American Journal of Neuroradiology. 39(3). 479–484. 48 indexed citations

Lichter, David, et al.. (2018). Progressive Supranuclear Palsy: New Diagnostic and Therapeutic Strategies. 1(2).

Lichter, David, et al.. (2014). Influence of Gender on Tourette Syndrome Beyond Adolescence. European Psychiatry. 30(2). 334–340. 41 indexed citations

Hagemeier, Jesper, Mari Heininen‐Brown, Tereza Gabelić, et al.. (2014). Phase White Matter Signal Abnormalities in Patients with Clinically Isolated Syndrome and Other Neurologic Disorders. American Journal of Neuroradiology. 35(10). 1916–1923. 8 indexed citations

Edwards, Keith R., Donald R. Royall, Linda A. Hershey, et al.. (2007). Efficacy and Safety of Galantamine in Patients with Dementia with Lewy Bodies: A 24-Week Open-Label Study. Dementia and Geriatric Cognitive Disorders. 23(6). 401–405. 64 indexed citations

10.

Edwards, Keith R., Linda A. Hershey, Laura O. Wray, et al.. (2003). Efficacy and Safety of Galantamine in Patients with Dementia with Lewy Bodies: A 12-Week Interim Analysis. Dementia and Geriatric Cognitive Disorders. 17(Suppl. 1). 40–48. 44 indexed citations

11.

Wood, Beatrice L., et al.. (2003). Pilot study of effect of emotional stimuli on tic severity in children with Tourette's syndrome. Movement Disorders. 18(11). 1392–1395. 40 indexed citations

12.

Lichter, David & Jeffrey L. Cummings. (2001). Frontal-subcortical circuits in psychiatric and neurological disorders. Guilford Press eBooks. 160 indexed citations

13.

Lichter, David, et al.. (1997). Genomic imprinting in Tourette's syndrome. Neurology. 49(2). 638–638. 2 indexed citations

14.

Lichter, David. (1997). Preclinical and Clinical Strategies for the Treatment of Neurodegenerative, Cerebrovascular and Mental Disorders. Neurology. 49(2). 645–645. 6 indexed citations

15.

Shucard, David W., Ralph H. B. Benedict, Ayda Tekok-Kılıç, & David Lichter. (1997). Slowed reaction time during a continuous performance test in children with Tourette's syndrome.. Neuropsychology. 11(1). 147–155. 40 indexed citations

16.

Lichter, David & Lisa A. Jackson. (1996). Predictors of Clonidine Response in Tourette Syndrome: Implications and Inferences. Journal of Child Neurology. 11(2). 93–97. 21 indexed citations

17.

Kurlan, Roger, Caroline M. Tanner, Christopher G. Goetz, et al.. (1994). Levodopa Drug Holiday Versus Drug Dosage Reduction in Parkinsonʼs Disease. Clinical Neuropharmacology. 17(2). 117–127. 5 indexed citations

18.

Kurlan, Roger, Jill Behr, Adrian Leibovici, et al.. (1989). Carbamazepine-Induced Tics. Clinical Neuropharmacology. 12(4). 298–302. 31 indexed citations

19.

Lichter, David, et al.. (1988). Opiate Withdrawal Unmasks Touretteʼs Syndrome. Clinical Neuropharmacology. 11(6). 559–564. 16 indexed citations

20.

Lichter, David. (1988). Cognitive and Motor Dysfunction in Parkinson's Disease. Archives of Neurology. 45(8). 854–854. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact